Condition: Right Ventricular Outflow Tract Dysfunction · Sponsor: Venus MedTech (HangZhou) Inc.
Real-world evidence, retrospective and prospective, non-randomized, multicenter observational study of VenusP-ValveTM System in treating moderate or greater pulmonary regurgitation with/without pulmonary stenosis in patients with native right ventricular outflow tract (RVOT).
This description comes directly from the study's public registry record.
Cong Ma · +86 18817939751 · macong@venusmedtech.com
Ping Zhang · 15802168031 · zhangping@venusmedtech.com
Always discuss trial participation with your own doctor first.
| CHU Bordeaux | Pessac, New Aquitaine, France | Not Yet Recruiting |
| Chu Nantes | Nantes, Pays de la Loire Region, France | Recruiting |
| Marie Lannelongue | Le Plessis-Robinson, Île-de-France Region, France | Recruiting |
| Hopital Necker-Enfants malades | Paris, Île-de-France Region, France | Recruiting |
| Heart CenterMunich | Munich, Bavaria, Germany | Not Yet Recruiting |
| Clinic of Congenital Heart Disease | Berlin, State of Berlin, Germany | Not Yet Recruiting |
| OPBG Rome | Rome, Lazio, Italy | Not Yet Recruiting |
| S. Donato Milan | Milan, Lombardy, Italy | Not Yet Recruiting |
| Leeds General Infirmary | Leeds, England, United Kingdom | Not Yet Recruiting |
| Evelina Children's Hospital | London, England, United Kingdom | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05835349